XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Comprehensive Income
Treasury Stock
Noncontrolling Interest
Total
Balance at Dec. 31, 2017 $ 11,875 $ 14,874,924 $ (6,634,067) $ 743,763 $ (9,100,000) $ 806,761 $ 703,256
Balance, Shares at Dec. 31, 2017 11,874,814       (275,347)    
Issuance of common shares $ 10 79,990         80,000
Issuance of common shares, Shares 9,990            
Stock based compensation   5,626         5,626
Net loss for the period     (601,387)     (112,235) (713,622)
Cumulative transaction adjustments       64,994     64,994
Balance at Mar. 31, 2018 $ 11,885 14,960,540 (7,235,454) 808,757 $ (9,100,000) 694,526 140,254
Balance, Shares at Mar. 31, 2018 11,884,804       (275,347)    
Stock based compensation   10,200         10,200
Net loss for the period     (632,170)     (103,870) (736,040)
Cumulative transaction adjustments       (134,054)      
Balance at Jun. 30, 2018 $ 11,885 14,970,740 (7,867,624) 674,703 $ (9,100,000) 590,656 (719,640)
Balance, Shares at Jun. 30, 2018 11,884,804       (275,347)    
Balance at Dec. 31, 2018 $ 11,885 14,983,714 (12,209,446) 655,851 $ (9,100,000) 317,610 (5,340,386)
Balance, Shares at Dec. 31, 2018 11,884,804       (275,347)    
Issuance of common shares to BioKey $ 1,642 692,577         694,219
Issuance of common shares to BioKey, Shares 1,642,291            
Issuance of common shares to BioLite $ 4,167 (4,167)          
Issuance of common shares to BioLite, Shares 4,166,530            
Stock based compensation   8,550         8,550
Net loss for the period     (791,671)     (81,646) (873,317)
Cumulative transaction adjustments       (15,412)     (15,412)
Balance at Mar. 31, 2019 $ 17,694 15,680,674 (13,001,117) 640,439 $ (9,100,000) 235,964 (5,526,346)
Balance, Shares at Mar. 31, 2019 17,693,625       (275,347)    
Balance at Dec. 31, 2018 $ 11,885 14,983,714 (12,209,446) 655,851 $ (9,100,000) 317,610 (5,340,386)
Balance, Shares at Dec. 31, 2018 11,884,804       (275,347)    
Balance at Jun. 30, 2019 $ 18,123 18,688,045 (13,558,693) 632,010 $ (9,100,000) 179,087 (3,141,428)
Balance, Shares at Jun. 30, 2019 18,122,196       (275,347)    
Balance at Mar. 31, 2019 $ 17,694 15,680,674 (13,001,117) 640,439 $ (9,100,000) 235,964 (5,526,346)
Balance, Shares at Mar. 31, 2019 17,693,625       (275,347)    
Issuance of common shares $ 429 2,999,571         3,000,000
Issuance of common shares, Shares 428,571            
Stock based compensation   7,800         7,800
Net loss for the period     (557,576)     (56,877) (614,453)
Cumulative transaction adjustments       (8,429)     (8,429)
Balance at Jun. 30, 2019 $ 18,123 $ 18,688,045 $ (13,558,693) $ 632,010 $ (9,100,000) $ 179,087 $ (3,141,428)
Balance, Shares at Jun. 30, 2019 18,122,196       (275,347)